AIG
RIGL icon

American International Group’s Rigel Pharmaceuticals RIGL Stock Holding History

American International Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,434
Closed -$125K – 2144
2024
Q1 		$125K Sell
8,434
-72
-0.8% -$970 ﹤0.01% 2396
2023
Q4 		$123K Sell
8,506
-34
-0.4% -$348 ﹤0.01% 2443
2023
Q3 		$92.2K Buy
8,540
+303
+4% +$3.65K ﹤0.01% 2550
2023
Q2 		$106K Sell
8,237
-92
-1% -$1.24K ﹤0.01% 2538
2023
Q1 		$110K Buy
8,329
+166
+2% +$2.64K ﹤0.01% 2413
2022
Q4 		$122K Sell
8,163
-30
-0.4% -$275 ﹤0.01% 2413
2022
Q3 		$97K Buy
8,193
+116
+1% +$1.57K ﹤0.01% 2576
2022
Q2 		$91K Sell
8,077
-406
-5% -$8.15K ﹤0.01% 2655
2022
Q1 		$254K Sell
8,483
-597
-7% -$16.2K ﹤0.01% 2099
2021
Q4 		$241K Sell
9,080
-272
-3% -$8.21K ﹤0.01% 2261
2021
Q3 		$339K Sell
9,352
-222
-2% -$8.74K ﹤0.01% 2096
2021
Q2 		$415 Sell
9,574
-330
-3% -$12.5K ﹤0.01% 2047
2021
Q1 		$339 Buy
9,904
+26
+0.3% +$1.03K ﹤0.01% 2059
2020
Q4 		$346 Sell
9,878
-283
-3% -$8.19K ﹤0.01% 1966
2020
Q3 		$244K Sell
10,161
-231
-2% -$5.67K ﹤0.01% 2020
2020
Q2 		$190K Buy
10,392
+434
+4% +$7.81K ﹤0.01% 2156
2020
Q1 		$155K Sell
9,958
-576
-5% -$12.3K ﹤0.01% 2055
2019
Q4 		$225K Sell
10,534
-88
-0.8% -$1.81K ﹤0.01% 2145
2019
Q3 		$199K Sell
10,622
-74
-0.7% -$1.53K ﹤0.01% 2171
2019
Q2 		$279K Sell
10,696
-10
-0.1% -$226 ﹤0.01% 2025
2019
Q1 		$275K Sell
10,706
-347
-3% -$7.93K ﹤0.01% 2034
2018
Q4 		$254K Sell
11,053
-85
-0.8% -$2.4K ﹤0.01% 2050
2018
Q3 		$358K Buy
11,138
+389
+4% +$11.7K ﹤0.01% 2078
2018
Q2 		$304K Buy
10,749
+1,293
+14% +$46K ﹤0.01% 2128
2018
Q1 		$335K Sell
9,456
-508
-5% -$20.3K ﹤0.01% 1955
2017
Q4 		$387K Buy
9,964
+1,676
+20% +$63.8K ﹤0.01% 1930
2017
Q3 		$211K Buy
8,288
+619
+8% +$15.1K ﹤0.01% 2262
2017
Q2 		$209K Buy
7,669
+179
+2% +$4.9K ﹤0.01% 2241
2017
Q1 		$248K Buy
7,490
+2,134
+40% +$54.4K ﹤0.01% 2045
2016
Q4 		$127K Sell
5,356
-13
-0.2% -$372 ﹤0.01% 2465
2016
Q3 		$197K Buy
5,369
+8
+0.1% +$229 ﹤0.01% 2173
2016
Q2 		$120K Buy
5,361
+199
+4% +$4.95K ﹤0.01% 2484
2016
Q1 		$107K Hold
5,162
– – ﹤0.01% 3376
2015
Q4 		$156K Sell
5,162
-9
-0.2% -$273 ﹤0.01% 3087
2015
Q3 		$128K Buy
5,171
+6
+0.1% +$179 ﹤0.01% 3259
2015
Q2 		$166K Sell
5,165
-407
-7% -$15.5K ﹤0.01% 3181
2015
Q1 		$199K Buy
5,572
+68
+1% +$1.86K ﹤0.01% 2950
2014
Q4 		$125K Sell
5,504
-218
-4% -$4.41K ﹤0.01% 3380
2014
Q3 		$111K Sell
5,722
-4
-0.1% -$113 ﹤0.01% 3465
2014
Q2 		$208K Sell
5,726
-199
-3% -$6.76K ﹤0.01% 2946
2014
Q1 		$230K Buy
5,925
+142
+2% +$5.06K ﹤0.01% 2725
2013
Q4 		$165K Sell
5,783
-58
-1% -$1.7K ﹤0.01% 2930
2013
Q3 		$209K Sell
5,841
-33
-0.6% -$1.2K ﹤0.01% 2695
2013
Q2 		$196K Buy
+5,874
New +$266K ﹤0.01% 2589

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

American International Group's RIGL Position: Q2 2024 in Review

American International Group sold out of Rigel Pharmaceuticals (RIGL) in Q2 2024, closing a stake of 8,434 shares — an estimated $125K sold.

American International Group first reported a position in RIGL in Q2 2013 and held it in 44 quarters. The position peaked at $387K in Q4 2017. 91 funds tracked by Wall St. Rank hold RIGL as of Q2 2024.

  • American International Group reported no remaining Rigel Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 8,434 Rigel Pharmaceuticals shares in Q2 2024, an estimated $125K.
  • American International Group first reported a position in Rigel Pharmaceuticals in Q2 2013 and held it in 44 quarters.
  • American International Group's Rigel Pharmaceuticals position peaked at $387K in Q4 2017.
  • 91 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.